{"id":{"repo_id":"wfu","oai_identifier":"oai:wakespace.lib.wfu.edu:10339/30393"},"canonical_url":"https://search.dev.ndltd.org/etd/wfu/oai:wakespace.lib.wfu.edu:10339/30393","repository":{"repo_id":"wfu","name":"Wake Forest University","base_url":"https://wakespace.lib.wfu.edu/oai/request"},"display":{"title":"POSTTRIAL CLINICAL ACCESS: AN EXAMINATION OF THE PRINCIPLES AND GUIDELINES SUPPORTING THE POSTTRIAL ACCESS FRAMEWORK AND A DETERMINATION OF WHETHER THE UNITED STATES CAN DEVELOP A GUIDANCE MANDATING THE PROVISION OF POSTTRIAL ACCESS","abstract":"The increased numbers of clinical trials taking place developing countries have raised issues concerning the researcher's obligation to trial participants, the host community, or the host country at the conclusion of a clinical trial. One of the most controversial obligations is the provision of posttrial access after a clinical research trial. This thesis summarizes the principles and guidelines that suggest or require the inclusion of a posttrial access framework at the conclusion of a clinical research trial in the specific context of HIV antiretroviral clinical trials conducted in developing countries, and determines whether the National Institutes of Health's existing posttrial access provision adequately addresses the issues related to mandating posttrial access.","abstract_html":"The increased numbers of clinical trials taking place developing countries have raised issues concerning the researcher's obligation to trial participants, the host community, or the host country at the conclusion of a clinical trial. One of the most controversial obligations is the provision of posttrial access after a clinical research trial. This thesis summarizes the principles and guidelines that suggest or require the inclusion of a posttrial access framework at the conclusion of a clinical research trial in the specific context of HIV antiretroviral clinical trials conducted in developing countries, and determines whether the National Institutes of Health's existing posttrial access provision adequately addresses the issues related to mandating posttrial access.","abstract_has_math":false,"creators":["Barner, Dionne Doshia"],"institution":"Wake Forest University","degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":[],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2010,"date_issued":"2010","date_published":"2010","updated_at":"2026-07-27T22:01:07Z","subjects":["AIDS"],"languages":["en"],"rights":[],"rights_urls":[],"identifier_entries":[]},"links":{"outbound_url":"http://hdl.handle.net/10339/30393","outbound_label":"Handle","outbound_source":"dc:identifier.uri"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:creator","label":"Author","values":["Barner, Dionne Doshia"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2011-02-16T21:42:12Z"]},{"key":"dc:date.available","label":"Dc Date Available","values":["2011-12-16T09:30:12Z"]},{"key":"dc:date.issued","label":"Date","values":["2010"]},{"key":"dc:publisher","label":"Institution","values":["Wake Forest University"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["AIDS"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["http://hdl.handle.net/10339/30393"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["The increased numbers of clinical trials taking place developing countries have raised issues concerning the researcher's obligation to trial participants, the host community, or the host country at the conclusion of a clinical trial. One of the most controversial obligations is the provision of posttrial access after a clinical research trial. This thesis summarizes the principles and guidelines that suggest or require the inclusion of a posttrial access framework at the conclusion of a clinical research trial in the specific context of HIV antiretroviral clinical trials conducted in developing countries, and determines whether the National Institutes of Health's existing posttrial access provision adequately addresses the issues related to mandating posttrial access."]},{"key":"dc:title","label":"Title","values":["POSTTRIAL CLINICAL ACCESS: AN EXAMINATION OF THE PRINCIPLES AND GUIDELINES SUPPORTING THE POSTTRIAL ACCESS FRAMEWORK AND A DETERMINATION OF WHETHER THE UNITED STATES CAN DEVELOP A GUIDANCE MANDATING THE PROVISION OF POSTTRIAL ACCESS"]}]}],"canonical_facts":{"dc:creator":["Barner, Dionne Doshia"],"dc:date.accessioned":["2011-02-16T21:42:12Z"],"dc:date.available":["2011-12-16T09:30:12Z"],"dc:date.issued":["2010"],"dc:description.abstract":["The increased numbers of clinical trials taking place developing countries have raised issues concerning the researcher's obligation to trial participants, the host community, or the host country at the conclusion of a clinical trial. One of the most controversial obligations is the provision of posttrial access after a clinical research trial. This thesis summarizes the principles and guidelines that suggest or require the inclusion of a posttrial access framework at the conclusion of a clinical research trial in the specific context of HIV antiretroviral clinical trials conducted in developing countries, and determines whether the National Institutes of Health's existing posttrial access provision adequately addresses the issues related to mandating posttrial access."],"dc:identifier.uri":["http://hdl.handle.net/10339/30393"],"dc:language.iso":["en"],"dc:publisher":["Wake Forest University"],"dc:subject":["AIDS"],"dc:title":["POSTTRIAL CLINICAL ACCESS: AN EXAMINATION OF THE PRINCIPLES AND GUIDELINES SUPPORTING THE POSTTRIAL ACCESS FRAMEWORK AND A DETERMINATION OF WHETHER THE UNITED STATES CAN DEVELOP A GUIDANCE MANDATING THE PROVISION OF POSTTRIAL ACCESS"],"dc:type":["Thesis"]},"updated_at":"2026-07-27T22:01:07Z"}